The new Alzheimer's drug: Why Donanemab, yet to be approved, has generated excitement

Donanemab was found to slow down cognitive decline by 35% in people with early Alzheimer’s. How does the drug work?

Related Keywords

India ,Japan ,United States ,American ,Japanese ,Eli Lilly ,Padma Srivastava ,India Institute Of Medical Sciences ,Drug Administration ,All India Institute ,Medical Sciences ,Disease Rating Scale ,Clinical Dementia Rating Sum ,Alzheimers Drug Donanemab ,Lecanemab ,Ow To Treat Alzheimer S ,Ow To Prevent Alzheimers ,Alzheimers Symptoms ,Xpress Explained ,Ndian Express ,